Biotech Buzz: Big Moves and Setbacks
In the fast-paced world of biotech, big names are making headlines. Pfizer's CEO, Albert Bourla, recently praised President Trump's Operation Warp Speed, even suggesting he might deserve a Nobel Prize. Meanwhile, Atlas Venture has raised a massive $400 million fund, but only a select few startups will get a chance to benefit from it. Agios Pharmaceuticals is facing ...